Picture of Journey Medical logo

DERM Journey Medical Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual income statement for Journey Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Revenue
Total Revenue34.944.563.173.7
Cost of Revenue
Gross Profit24.429.931.142.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses29.736.798101
Operating Profit5.267.85-34.9-27.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes57.15-42.4-29.6
Provision for Income Taxes
Net Income After Taxes3.635.28-44-29.6
Net Income Before Extraordinary Items
Net Income3.635.28-44-29.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income3.635.28-44-29.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.220.321-4.32-1.68
Dividends per Share